Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance

Diabetes

Volumn 46, Issue 3, 1997, Pages 451-455

  Hotamisligil, Gökhan S ^a   Arner, Peter ^c   Atkinson, Richard L ^d   Spiegelman, Bruce M ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; NORMAL HUMAN; NORTHERN BLOTTING; OBESITY; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0031053823     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.3.451     Document Type: Article

References (32)

1. Beutler B, Cerami A: The biology of cachectin/TNF-α primary mediator of the host response. Ann Rev Immunol 7:625-655, 1989
2. Old LJ: Tumor necrosis factor (TNF). Science 230:630-633, 1985
3. Grunfeld C, Feingold KR: The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 3:143-158, 1991
4. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
5. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJJR, Hotamisligil GS, Spiegelman BM: Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270, 1994
6. Hotamisligil GS, Spiegelman BM: TNFα: a key component of obesity-diabetes link. Diabetes 43:1271-1278, 1994
7. Hamann A, Benecke H, Le Marchand-Brustel Y, Susulic VS, Lowell BB, Flier JS: Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes 44:1266-1273, 1995
8. Hotamisligil GS, Budavari A, Murray DL, Spiegelman BM: Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: central role of tumor necrosis factor-α. J Clin Invest 94:1543-1549, 1994
9. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
10. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumor necrosis factor in adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119, 1995
11. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA: The expression of TNFα by human muscle: relationship to insulin resistance. J Clin Invest 97:1111-1116, 1996
12. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM: TNF-α inhibits signaling from insulin receptor. Proc Natl Acad Sci USA 91:4854-4858, 1994
13. Tartaglia LA, Goeddel DV: Two TNF receptors. Immunol Today 13:151-153, 1992
14. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76:959-962, 1994
15. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino JMA, Goeddel DV: The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88:9292-9296, 1991
16. Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV: A novel domain within the 55 kD TNF receptor signals cell death. Cell 74:845-853, 1993
17. Zheng L, Fisher G, Miller RE, Peschon J, Lynch D, Lenardo MJ: Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348-351, 1995
18. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299, 1979
19. Spiegelman BM, Frank M, Green H: Molecular cloning of mRNA from 3T3 adipocytes: regulation of mRNA content for glycerolphosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development. J Biol Chem 258:10083-10089, 1983
20. Loetscher H, Pan YC, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W: Molecular cloning and expression of the human 55 kD tumor necrosis factor receptor. Cell 61:351-359, 1990
21. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GH, Gatanaga T, Granger GA, Lentz R, Raab H, Kohr WJ, Goeddel DV: Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61:361-370, 1990
22. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019-1023, 1990
23. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R: Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45:881-885, 1996
24. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A: Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268:26055-26058, 1993
25. Kroder G, Bossenmaier B, Kellerer M, Capp E, Stoyanov B, Mühlhöfer A, Berti L, Horikoshi H, Ullrich A, Haring H: Tumor necrosis factor-α- and hyperglycemia-induced insulin resistance: evidence for different mechanisms and different effects on insulin signaling. J Clin Invest 97:1471-1477, 1996
26. Hotamisligil GH, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271:665-668, 1996
27. Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A: Tumor necrosis factor-α-induced phosphorylation of insulin receptor substrate-1 (IRS-1). J Biol Chem 270:23780-23784, 1995
28. Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM: Tumor necrosis factor (TNF)-α inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271:13018-13022, 1996
29. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D: Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323-329, 1992
30. Evans TJ, Moyes D, Carpenter A, Martin R, Loetscher H, Lesslauer W, van der Linden CJ: Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gramnegative sepsis. J Exp Med 180:2171-2179, 1994
31. Winzen R, Wallach D, Kemper O, Resch K, Holtmann H: Selective upregulation of the 75-kDa tumor necrosis (TNF) receptor and its mRNA by TNF and IL-1. Immunol 150:4346-4353, 1993
32. Engelberts I, Stephens S, Francot GJ, van der Linden CJ, Buurman WA: Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet 338:515-516, 1991